Free Trial
NYSE:ELAN

Elanco Animal Health (ELAN) Stock Price, News & Analysis

Elanco Animal Health logo
$14.88 -0.02 (-0.16%)
Closing price 07/14/2025 03:59 PM Eastern
Extended Trading
$14.88 +0.01 (+0.06%)
As of 07/14/2025 07:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Elanco Animal Health Stock (NYSE:ELAN)

Key Stats

Today's Range
$14.68
$14.93
50-Day Range
$9.53
$15.06
52-Week Range
$8.02
$15.78
Volume
3.82 million shs
Average Volume
5.07 million shs
Market Capitalization
$7.39 billion
P/E Ratio
20.10
Dividend Yield
N/A
Price Target
$15.33
Consensus Rating
Moderate Buy

Company Overview

Elanco Animal Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
30th Percentile Overall Score

ELAN MarketRank™: 

Elanco Animal Health scored higher than 30% of companies evaluated by MarketBeat, and ranked 803rd out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Elanco Animal Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 4 buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Elanco Animal Health has only been the subject of 2 research reports in the past 90 days.

  • Read more about Elanco Animal Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Elanco Animal Health are expected to decrease by -2.20% in the coming year, from $0.91 to $0.89 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Elanco Animal Health is 20.10, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.26.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Elanco Animal Health is 20.10, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.69.

  • Price to Earnings Growth Ratio

    Elanco Animal Health has a PEG Ratio of 2.91. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Elanco Animal Health has a P/B Ratio of 1.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Elanco Animal Health's valuation and earnings.
  • Percentage of Shares Shorted

    5.08% of the float of Elanco Animal Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Elanco Animal Health has a short interest ratio ("days to cover") of 4.1.
  • Change versus previous month

    Short interest in Elanco Animal Health has recently increased by 3.01%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Elanco Animal Health does not currently pay a dividend.

  • Dividend Growth

    Elanco Animal Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.08% of the float of Elanco Animal Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Elanco Animal Health has a short interest ratio ("days to cover") of 4.1.
  • Change versus previous month

    Short interest in Elanco Animal Health has recently increased by 3.01%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Elanco Animal Health has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.98 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Elanco Animal Health this week, compared to 13 articles on an average week.
  • Search Interest

    8 people have searched for ELAN on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Elanco Animal Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.89% of the stock of Elanco Animal Health is held by insiders.

  • Percentage Held by Institutions

    97.48% of the stock of Elanco Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Elanco Animal Health's insider trading history.
Receive ELAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elanco Animal Health and its competitors with MarketBeat's FREE daily newsletter.

ELAN Stock News Headlines

ELAN - Elanco Animal Health Inc Executives | Morningstar
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.
Elanco's dog flu vaccine gets USDA nod
See More Headlines

ELAN Stock Analysis - Frequently Asked Questions

Elanco Animal Health's stock was trading at $12.11 at the beginning of 2025. Since then, ELAN shares have increased by 22.8% and is now trading at $14.8760.

Elanco Animal Health Incorporated (NYSE:ELAN) issued its quarterly earnings results on Wednesday, May, 7th. The company reported $0.37 EPS for the quarter, beating analysts' consensus estimates of $0.31 by $0.06. The firm's revenue for the quarter was down 1.0% on a year-over-year basis.
Read the conference call transcript
.

Elanco Animal Health (ELAN) raised $1.4 billion in an initial public offering on Thursday, September 20th 2018. The company issued 62,900,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Barclays, BNP PARIBAS, BofA Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank Securities, Evercore ISI, Cowen, Academy Securities, Drexel Hamilton, Mischler Financial Group, Ramirez and The Williams Capital Group were co-managers.

Top institutional shareholders of Elanco Animal Health include Douglas Lane & Associates LLC (0.71%), Harbor Capital Advisors Inc. (0.16%), Sapient Capital LLC (0.03%) and Hedges Asset Management LLC (0.02%). Insiders that own company stock include R David Hoover, Jeffrey N Simmons, Lawrence Erik Kurzius, Michael J Harrington, John P Bilbrey and Rajeev A Modi.
View institutional ownership trends
.

Shares of ELAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Elanco Animal Health investors own include Salesforce (CRM), Home Depot (HD), Chevron (CVX), Pfizer (PFE), Bank of America (BAC), QUALCOMM (QCOM) and AbbVie (ABBV).

Company Calendar

Last Earnings
5/07/2025
Today
7/14/2025
Next Earnings (Estimated)
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:ELAN
CIK
1739104
Fax
N/A
Employees
9,000
Year Founded
N/A

Price Target and Rating

High Price Target
$19.00
Low Price Target
$12.00
Potential Upside/Downside
+3.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.74
Trailing P/E Ratio
20.10
Forward P/E Ratio
16.35
P/E Growth
2.91
Net Income
$338 million
Net Margins
8.43%
Pretax Margin
12.11%
Return on Equity
7.54%
Return on Assets
3.57%

Debt

Debt-to-Equity Ratio
0.68
Current Ratio
2.71
Quick Ratio
1.46

Sales & Book Value

Annual Sales
$4.44 billion
Price / Sales
1.66
Cash Flow
$2.25 per share
Price / Cash Flow
6.61
Book Value
$12.33 per share
Price / Book
1.21

Miscellaneous

Outstanding Shares
496,650,000
Free Float
492,226,000
Market Cap
$7.39 billion
Optionable
Optionable
Beta
1.67
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:ELAN) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners